Optimizing pre-participation screening to prevent tragedy in young athletes: moving from if to how.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Population-based screening for conditions associated with juvenile sudden cardiac death: a systematic review and meta-analysis.European heart journal. Quality of care & clinical outcomes · 2026
   Pooled it
2. Towards smarter screening: refining ECG criteria for the youngest athletes.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
   Article
3. Preparticipation Cardiovascular Screening of Athletes: Current Controversies and Challenges for the Future.Diagnostics (Basel, Switzerland) · 2024
   Review

Corrections and comments

• Comment on
  Value of screening for the risk of sudden cardiac death in young competitive athletes.2023

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as